台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效

逸達

(6576)
  • 股價
    63.6
  • 漲跌
    ▲5.7
  • 漲幅
    +9.84%
  • 成交量
    171
  • 產業
    上櫃 生技醫療類股
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
逸達 (6576)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2025/04/01     後一日»

券商獲利排行 - 2025/04/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  18.93%371.30371.3-2502578.5078.563.6
  18.99%149.10149.1-1001078.5078.563.6
  19.02%119.50119.5-80878.5078.563.6
  19.02%74.7074.7-50578.5078.563.6
  11.28%62.30.761.6-43778.978.87963.6
  19.49%30.8030.8-2027907963.6
  19.19%30.2030.2-10278.778.278.763.6
  18.98%29.8029.8-20278.5078.563.6
  18.88%29.6029.6-20278.4078.463.6
  19.60%15.5015.5-10179.1079.163.6
  19.60%15.5015.5-10179.1079.163.6
  19.60%15.5015.5-10179.1079.163.6
  19.49%15.4015.4-1017907963.6
  19.49%15.4015.4-1017907963.6
  19.49%15.4015.4-1017907963.6
  18.93%14.9014.9-10178.5078.563.6
  18.88%14.8014.8-10178.4078.463.6
  18.77%14.7014.7-10178.3078.363.6
  18.67%14.6014.6-10178.2078.263.6
  0.89%0.70.7001178.778.37963.6
   0000007979063.6
   00000078.678.6063.6
   00000079.5079.563.6
   00000078.6078.663.6
   00000078.378.3063.6
   00000078.578.5063.6
   00000079.579.5063.6
   00000079.579.5063.6
   00000078.678.6063.6
   0000007907963.6
   00000079.579.5063.6
   00000078.7078.763.6
   00000078.5078.563.6
   00000078.278.378.263.6
   00000078.2078.263.6
   00000079.4079.463.6
   00000078.6078.663.6
   00000078.678.579.463.6
   00000078.3078.363.6
   00000078.678.6063.6
   00000079.5079.563.6
   00000078.278.2063.6
   00000078.378.3063.6
   00000079.579.5063.6
   00000078.478.4063.6
   00000078.678.6063.6
   00000079.379.3063.6
   00000078.5078.563.6
   00000079.779.7063.6
   00000079.479.4063.6

券商虧損排行 - 2025/04/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -19.36%-351.20-351.22323078.978.9063.6
  -18.96%-148.80-148.81010078.578.5063.6
  -18.84%-73.80-73.855078.478.4063.6
  -19.60%-46.50-46.533079.179.1063.6
  -18.88%-44.40-44.433078.478.4063.6
  -18.74%-440-4433078.378.3063.6
  -18.90%-29.60-29.622078.478.4063.6
  -18.77%-29.40-29.422078.378.3063.6
  -19.60%-15.50-15.511079.179.1063.6
  -19.49%-15.40-15.41107979063.6
  -18.98%-14.90-14.911078.578.578.563.6
  -18.98%-14.90-14.911078.578.5063.6
  -18.98%-14.90-14.911078.578.5063.6
  -18.98%-14.90-14.911078.578.5063.6
  -18.98%-14.90-14.911078.578.5063.6
  -18.88%-14.80-14.811078.478.4063.6
  -18.88%-14.80-14.811078.478.4063.6
  -18.88%-14.80-14.811078.478.4063.6
  -18.88%-14.80-14.811078.478.4063.6
  -18.77%-14.70-14.711078.378.3063.6
  -18.77%-14.70-14.711078.378.3063.6
  -18.77%-14.70-14.711078.378.3063.6
  -18.77%-14.70-14.711078.378.3063.6
  -18.77%-14.70-14.701078.378.378.563.6
  -18.67%-14.60-14.611078.278.2063.6
  -18.67%-14.60-14.611078.278.2063.6
   00000078.378.3063.6
   00000079.579.5063.6
   00000078.5078.563.6
   00000079.779.7063.6
   00000079.479.4063.6
   00000078.378.3063.6
   00000079.379.3063.6
   00000079.5079.563.6
   00000078.6078.663.6
   00000078.578.5063.6
   00000078.478.4063.6
   00000078.678.6063.6
   00000078.678.579.463.6
   00000078.3078.363.6
   00000078.3078.363.6
   00000078.9078.963.6
   00000078.5078.563.6
   00000078.678.6063.6
   0000007979063.6
   00000078.678.6063.6
   0000007907963.6
   00000079.579.5063.6
   00000078.7078.763.6
   00000079.579.5063.6
逸達兒童中樞性早熟三期臨床 三度獲DSMB正面回饋持續進行Anue鉅亨-2025/02/17
逸達受美國經銷商指示不定期出貨 1月營收年減逾6成Anue鉅亨-2025/02/08
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-2025/01/14
逸達 相關文章
逸達 相關影音